Cargando…

Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.

In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution....

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungberg, B., Mehle, C., Stenling, R., Roos, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074617/
https://www.ncbi.nlm.nih.gov/pubmed/8679445
_version_ 1782138005038825472
author Ljungberg, B.
Mehle, C.
Stenling, R.
Roos, G.
author_facet Ljungberg, B.
Mehle, C.
Stenling, R.
Roos, G.
author_sort Ljungberg, B.
collection PubMed
description In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution. We have studied 200 consecutive renal cell carcinomas, addressing the interrelationship between intratumour heterogeneity and clinicopathological factors. DNA ploidy patterns were analysed in multiple samples from each tumour using flow cytometry and compared with clinical stage, tumour invasion, metastatic rate and survival. Eighty-five of 192 evaluable tumours (44%) were homogeneous concerning DNA ploidy (62% diploid, 38% aneuploid). Among 107 heterogeneous tumours a majority (79%) contained aneuploid as well as diploid cell clones. Homogeneously diploid tumours had a lower incidence of local tumour spread compared with tumours with aneuploid cell clones (P < or = 0.001), but the frequency of distant metastasis at time of diagnosis was similar. The presence of aneuploidy in at least one sample from a tumour was a significant adverse prognostic factor (P < 0.001), whereas the degree of heterogeneity had no influence on survival. The frequent heterogeneity demonstrated indicates that multiple samples must be investigated to evaluate properly the malignant character of renal cell carcinoma.
format Text
id pubmed-2074617
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20746172009-09-10 Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study. Ljungberg, B. Mehle, C. Stenling, R. Roos, G. Br J Cancer Research Article In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution. We have studied 200 consecutive renal cell carcinomas, addressing the interrelationship between intratumour heterogeneity and clinicopathological factors. DNA ploidy patterns were analysed in multiple samples from each tumour using flow cytometry and compared with clinical stage, tumour invasion, metastatic rate and survival. Eighty-five of 192 evaluable tumours (44%) were homogeneous concerning DNA ploidy (62% diploid, 38% aneuploid). Among 107 heterogeneous tumours a majority (79%) contained aneuploid as well as diploid cell clones. Homogeneously diploid tumours had a lower incidence of local tumour spread compared with tumours with aneuploid cell clones (P < or = 0.001), but the frequency of distant metastasis at time of diagnosis was similar. The presence of aneuploidy in at least one sample from a tumour was a significant adverse prognostic factor (P < 0.001), whereas the degree of heterogeneity had no influence on survival. The frequent heterogeneity demonstrated indicates that multiple samples must be investigated to evaluate properly the malignant character of renal cell carcinoma. Nature Publishing Group 1996-07 /pmc/articles/PMC2074617/ /pubmed/8679445 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Ljungberg, B.
Mehle, C.
Stenling, R.
Roos, G.
Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title_full Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title_fullStr Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title_full_unstemmed Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title_short Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
title_sort heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074617/
https://www.ncbi.nlm.nih.gov/pubmed/8679445
work_keys_str_mv AT ljungbergb heterogeneityinrenalcellcarcinomaanditsimpactnoprognosisaflowcytometricstudy
AT mehlec heterogeneityinrenalcellcarcinomaanditsimpactnoprognosisaflowcytometricstudy
AT stenlingr heterogeneityinrenalcellcarcinomaanditsimpactnoprognosisaflowcytometricstudy
AT roosg heterogeneityinrenalcellcarcinomaanditsimpactnoprognosisaflowcytometricstudy